Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations.

Autor: Demurtas S; Internal Medicine and Therapeutics Department, University of Pavia, 27100 Pavia, Italy.; Unit of Medical Oncology, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy., Cena H; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.; Unit of Clinical Nutrition, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy., Benazzo M; Department of Otorhinolaryngology, University of Pavia, 27100 Pavia, Italy.; Department of Otolaryngology-Head and Neck Surgery, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy., Gabanelli P; Unit of Psychology, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy., Porcelli S; Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.; San Matteo Clinic IRCCS Foundation, 27100 Pavia, Italy., Preda L; Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.; Radiology Institute, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy., Bortolotto C; Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.; Radiology Institute, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy., Bertino G; Department of Otolaryngology-Head and Neck Surgery, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy., Mauramati S; Department of Otolaryngology-Head and Neck Surgery, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy., Veneroni MV; Department of Otolaryngology-Head and Neck Surgery, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy., Orlandi E; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.; Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy., Camarda AM; Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy., Madini N; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy., Raso CA; Internal Medicine and Therapeutics Department, University of Pavia, 27100 Pavia, Italy.; Unit of Medical Oncology, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy., Locati LD; Internal Medicine and Therapeutics Department, University of Pavia, 27100 Pavia, Italy.; Unit of Medical Oncology, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Oct 17; Vol. 13 (20). Date of Electronic Publication: 2024 Oct 17.

Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.

Autor: Camarda AM; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy.; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Vincini MG; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Russo S; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy., Comi S; Unit of Medical Physics, European Institute of Oncology IRCCS, Milan, Italy., Emiro F; Unit of Medical Physics, European Institute of Oncology IRCCS, Milan, Italy., Bazani A; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy., Ingargiola R; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy., Vischioni B; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy., Vecchi C; Tecnologie Avanzate Srl, Turin, Italy., Volpe S; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Orecchia R; Scientific Directorate, European Institute of Oncology IRCCS, Milan, Italy., Jereczek-Fossa BA; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Orlandi E; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy.; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences,University of Pavia, Italy., Alterio D; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Publikováno v: Tumori [Tumori] 2024 Aug; Vol. 110 (4), pp. 273-283. Date of Electronic Publication: 2024 May 21.

Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysis.

Autor: Orlandi E; Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: ester.orlandi@cnao.it., Fontana G; Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy., Licitra L; Scientific Directorate, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy; Department of Head & Neck Medical Oncology 3, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; Department of Oncology & Haemato-Oncology, University of Milan, 20122 Milan, Italy., Tinelli C; CNAO National Center for Oncological Hadrontherapy, Scientific Direction Office, Pavia, Italy., Camarda AM; Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy., Grau C; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Frank SJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Apr; Vol. 193, pp. 110122. Date of Electronic Publication: 2024 Feb 01.

Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO.

Autor: Vischioni B; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Ingargiola R; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Bonora M; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Ronchi S; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Camarda AM; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Russo S; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Rossi E; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Magro G; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Mirandola A; Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy., Orlandi E; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy.

Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Mar 31; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 31.

Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy.

Autor: Barcellini A; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Fontana G; Clinical Bioengineering Unit, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Filippini DM; Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy., Ronchi S; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy. Electronic address: sara.ronchi@cnao.it., Bonora M; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Vischioni B; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Ingargiola R; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Camarda AM; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Loap P; Department of Radiation Oncology, Institut Curie, Paris, France., Facchinetti N; Scientific Direction, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy., Licitra L; Scientific Direction, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Head and Neck Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Baroni G; Clinical Bioengineering Unit, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, Milan, Italy., Orlandi E; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Dec; Vol. 177, pp. 143-151. Date of Electronic Publication: 2022 Oct 31.